A study to find out the effectiveness of Homoeopathic medicines in Allergic asthma patients
Phase 3
- Conditions
- Health Condition 1: J454- Moderate persistent asthma
- Registration Number
- CTRI/2022/10/046524
- Lead Sponsor
- Dr GEETHU K P
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
1. Patient with age 18- 60 years of any gender.
2. Patients with reduction in FEV1 / FVC Ratio ( below 70 %)
3. Patient with increased serum IgE level.
4. Patient with signs and symptoms of allergic asthma.
Exclusion Criteria
1. Patients with immune deficiency diseases like AIDS, cancer etc
2. Patients with systemic illness that is contraindicated in spirometry (myocardial
infarction, pneumothorax , large aneurysm etc).
3. Status asthmaticus
4. Pregnant and lactating mother
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method To measure the changes in FEV1/FVC ratio in allergic bronchial asthma patients <br/ ><br>before and after individualized homoeopathic medicinesTimepoint: ENROLLMENT PERIOD - 6 MONTHS <br/ ><br>FOLLOW UP PERIOD - 1 YEAR
- Secondary Outcome Measures
Name Time Method 1. To determine any significant reduction in serum IgE level in allergic bronchial <br/ ><br>asthma with individualised homoeopathic medicines <br/ ><br>2. To find out changes in quality of life using Asthma Quality of life questionnaire <br/ ><br>with standardized activities AQLQ (s) <br/ ><br>3. To find out changes in severity of asthma in Primary asthma control screening <br/ ><br>tool <br/ ><br>4. To determine the frequency of inhaler used by patients with allergic asthma.Timepoint: ENROLLMENT PERIOD - 6 MONTHS <br/ ><br>FOLLOW UP PERIOD - 1 YEAR